[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.204.52.4. Please contact the publisher to request reinstatement.
[Skip to Content Landing]

Year

Day

March 21, 2019
Original Investigation

The Role of Disease Label in Patient Perceptions and Treatment Decisions in the Setting of Low-Risk Malignant Neoplasms

Abstract Full Text
has audio
JAMA Oncol. Published online March 21, 2019. doi:10.1001/jamaoncol.2019.0054

This survey study of 1068 US residents assesses the role that disease label plays in patients’ perceptions of low-risk malignant neoplasms and treatment decision making.

Effect of Taxane Plus Platinum Regimens vs Doxorubicin Plus Cisplatin as Adjuvant Chemotherapy for Endometrial Cancer at a High Risk of Progression: A Randomized Clinical Trial

Abstract Full Text
JAMA Oncol. Published online March 21, 2019. doi:10.1001/jamaoncol.2019.0001

This phase 3 randomized clinical trial evaluates the clinical benefit of taxane plus platinum regimens compared with standard doxorubicin plus cisplatin in postoperative adjuvant chemotherapy for endometrial cancer.

Implications of the Parenteral Opioid Shortage for Prescription Patterns and Pain Control Among Hospitalized Patients With Cancer Referred to Palliative Care

Abstract Full Text
JAMA Oncol. Published online March 21, 2019. doi:10.1001/jamaoncol.2019.0062

This cohort study analyzes the implications of the parenteral opioid shortage for opioid prescription patterns and pain management in hospitalized patients with cancer referred to palliative care.

Editorial

JAMA Oncology—The Year in Review, 2018

Abstract Full Text
free access
JAMA Oncol. Published online March 21, 2019. doi:10.1001/jamaoncol.2019.0231

Disease Labels and Clear Communication With Patients—A Rose by Any Other Name Would Smell as Sweet

Abstract Full Text
JAMA Oncol. Published online March 21, 2019. doi:10.1001/jamaoncol.2019.0053
Comment & Response

Hyperprogression—Immunotherapy-Related Phenomenon vs Intrinsic Natural History of Cancer

Abstract Full Text
JAMA Oncol. Published online March 21, 2019. doi:10.1001/jamaoncol.2019.0130

Hyperprogression—Immunotherapy-Related Phenomenon vs Intrinsic Natural History of Cancer—In Reply

Abstract Full Text
JAMA Oncol. Published online March 21, 2019. doi:10.1001/jamaoncol.2019.0138
Peer Reviewers List

JAMA Oncology Peer Reviewers in 2018

Abstract Full Text
free access
JAMA Oncol. Published online March 21, 2019. doi:10.1001/jamaoncol.2019.0109
March 14, 2019
Original Investigation

Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non–Small Cell Lung Cancer: A Long-term Update of the NRG Oncology/RTOG 0214 Phase 3 Randomized Clinical Trial

Abstract Full Text
JAMA Oncol. Published online March 14, 2019. doi:10.1001/jamaoncol.2018.7220

This phase 3 randomized clinical trial of 340 patients with locally advanced non–small cell lung cancer compares outcomes of treatment with prophylactic cranial irradiation vs observation.

Evaluating an Intervention to Improve Communication Between Oncology Clinicians and Patients With Life-Limiting Cancer: A Cluster Randomized Clinical Trial of the Serious Illness Care Program

Abstract Full Text
JAMA Oncol. Published online March 14, 2019. doi:10.1001/jamaoncol.2019.0292

This cluster randomized clinical trial evaluates secondary outcomes in the Serious Illness Care Program, an intervention to improve communication between oncology clinicians and patients with life-limiting cancer.

JAMA Oncology Clinical Challenge

Widespread Thickened, Verrucous, Hyperpigmented Plaques in a Woman With Weight Loss

Abstract Full Text
JAMA Oncol. Published online March 14, 2019. doi:10.1001/jamaoncol.2018.7153

A 30-year-old woman presented with a history of thickened, verrucous, hyperpigmented plaques distributed symmetrically over her body. She also had recent weight loss and an enlarged thyroid. What is your diagnosis?

Viewpoint

HER2 Amplification and Anti-EGFR Sensitivity in Advanced Colorectal Cancer

Abstract Full Text
JAMA Oncol. Published online March 14, 2019. doi:10.1001/jamaoncol.2018.7229

This Viewpoint questions a recently published treatment algorithm for patients with HER2-amplified metastatic colorectal cancer and proposes alternative timing for HER2 testing and HER2-directed therapies.

Editorial

Discussing Prognosis, Preferences, and End-of-Life Care in Advanced Cancer: We Need to Speak

Abstract Full Text
JAMA Oncol. Published online March 14, 2019. doi:10.1001/jamaoncol.2019.0291
Comment & Response

Undissected Axilla and Axillary Radiotherapy

Abstract Full Text
JAMA Oncol. Published online March 14, 2019. doi:10.1001/jamaoncol.2019.0031

Undissected Axilla and Axillary Radiotherapy—In Reply

Abstract Full Text
JAMA Oncol. Published online March 14, 2019. doi:10.1001/jamaoncol.2019.0050
March 7, 2019
Original Investigation

Long-term Somatic Disease Risk in Adult Danish Cancer Survivors

Abstract Full Text
JAMA Oncol. Published online March 7, 2019. doi:10.1001/jamaoncol.2018.7192

This nationwide, population-based cohort-cohort study of compares the temporal pattern of hospitalizations for medically verified incident somatic disease between cancer survivors and cancer-free people.

Association of Neurosurgical Resection With Development of Pachymeningeal Seeding in Patients With Brain Metastases

Abstract Full Text
JAMA Oncol. Published online March 7, 2019. doi:10.1001/jamaoncol.2018.7204

This cohort study assesses the association and incidence of pachymeningeal seeding after neurosurgical resection in patients with brain metastases treated with adjuvant stereotactic radiation.

Viewpoint

Unintended Consequences of the Right to Try Act for Palliative Care in Pediatric Oncology

Abstract Full Text
JAMA Oncol. Published online March 7, 2019. doi:10.1001/jamaoncol.2018.7201

This Viewpoint highlights potential unintended consequences that the Right to Try Act may have on palliative care for pediatric patients with cancer.

Poetry and Oncology

Beat of the Same Drum

Abstract Full Text
JAMA Oncol. Published online March 7, 2019. doi:10.1001/jamaoncol.2018.7167
Comment & Response

Level of Evidence and Ethical Considerations for Locoregional Treatments in Metastatic Cervical Cancer

Abstract Full Text
JAMA Oncol. Published online March 7, 2019. doi:10.1001/jamaoncol.2018.5096

Level of Evidence and Ethical Considerations for Locoregional Treatments in Metastatic Cervical Cancer—In Reply

Abstract Full Text
JAMA Oncol. Published online March 7, 2019. doi:10.1001/jamaoncol.2019.0028

Analyzing Frequently Mutated Genes and the Association With Tumor Mutation Load

Abstract Full Text
JAMA Oncol. Published online March 7, 2019. doi:10.1001/jamaoncol.2019.0127

Tumor Mutation Load and Frequently Mutated Genes in Gastric Cancer—In Reply

Abstract Full Text
JAMA Oncol. Published online March 7, 2019. doi:10.1001/jamaoncol.2019.0135

Omitted Disclosures of Potential Conflicts of Interest in Articles Published in JAMA Oncology

Abstract Full Text
JAMA Oncol. Published online March 7, 2019. doi:10.1001/jamaoncol.2019.0235
Correction

Incomplete Conflict of Interest Disclosures

Abstract Full Text
free access
JAMA Oncol. Published online March 7, 2019. doi:10.1001/jamaoncol.2019.0286

Errors in Author Affiliations and Additional Contributions

Abstract Full Text
free access
JAMA Oncol. Published online March 7, 2019. doi:10.1001/jamaoncol.2019.0220
×